Literature DB >> 18212238

Correlation of whole-breast vascularity with ipsilateral breast cancers using contrast-enhanced MDCT.

Doo Kyoung Kang1, Eun Jin Kim, Ho Sung Kim, Joo Sung Sun, Yong Sik Jung.   

Abstract

OBJECTIVE: The purpose of our study was to assess the increase in whole-breast vascularity in patients with unilateral breast cancer and correlate that increase with prognostic factors of breast cancer.
MATERIALS AND METHODS: We performed 16-MDCT on 143 consecutive patients with histologically confirmed breast cancer. One hundred three of these 143 patients were finally enrolled in the study after exclusion of patients with bilateral breast cancer, previous history of neoadjuvant chemotherapy, breast surgery, or lack of surgical confirmation. Breast vascularity was assessed according to the number, length, and conspicuity of vessels on maximum-intensity-projection images. Increase of whole-breast vascularity of the cancer-bearing breast was categorized as not increased, mild, moderate, or prominent compared with the contralateral breast. Breast vascularity was then correlated to prognostic factors including tumor size, lymph node status, cancer stage, nuclear and histologic grade, presence of an extensive intraductal component, presence of hormone receptors, and expression of C-erb-B2. RESULT: . In 77 (74.8%) of 103 patients, breast cancers were found to be associated with ipsilateral increased whole-breast vascularity. In the 77 patients with increased vascularity, prominent, moderate, and mild vascularity were shown in 21 (27.3%), 23 (29.9%), and 33 (42.9%) patients, respectively. Ipsilateral increased vascularity was related to tumor size, lymph node status, cancer stage, nuclear grade, and histologic grade. The presence of extensive intraductal component and hormone receptors and the expression of C-erb-B2 were not related to ipsilateral increased vascularity.
CONCLUSION: Breast cancers were found to be associated with ipsilateral increased whole-breast vascularity in a significant percentage of patients. Increased whole-breast vascularity indicated the growth and metastatic potential of a breast cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18212238     DOI: 10.2214/AJR.07.2784

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  6 in total

1.  Contrast-enhanced MR imaging of the breast: association between asymmetric increased breast vascularity and ipsilateral cancer in a consecutive series of 197 patients.

Authors:  N Verardi; G Di Leo; L A Carbonaro; M P Fedeli; F Sardanelli
Journal:  Radiol Med       Date:  2012-08-08       Impact factor: 3.469

2.  Comparison of diameters of ipsilateral and contralateral internal mammary arteries by breast MRI in patients with unilateral breast cancer.

Authors:  Kyung Jin Nam; Ki Seok Choo; Ung Bae Jeon; Tae Un Kim; Jae-Yeon Hwang; Jeong A Yeom; Hee Seok Jeong; Yoon Young Choi; Jin You Kim; Sang Hyup Lee; Hyun Yul Kim; Youn Joo Jung; Young Hye Cho
Journal:  Jpn J Radiol       Date:  2016-03-24       Impact factor: 2.374

3.  Adjacent vessel sign and breast imaging reporting and data system are valuable for diagnosis of benign and malignant breast lesions.

Authors:  Suhong Zhao; Ru Tan; Jianjun Xiu; Xianshun Yuan; Qingwei Liu
Journal:  Biotechnol Biotechnol Equip       Date:  2014-10-29       Impact factor: 1.632

4.  Dynamic contrast-enhanced breast magnetic resonance imaging for the prediction of early and late recurrences in breast cancer.

Authors:  Eun Jung Choi; HyeMi Choi; Sin Ae Choi; Ji Hyun Youk
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

5.  Bilateral analysis of the cross-sectional area of the internal mammary arteries and veins in patients with and without breast cancer on breast magnetic resonance imaging.

Authors:  Robert-Jan Schipper; Marc B I Lobbes; Rieky E Dikmans; Regina G H Beets-Tan; Marjolein L Smidt; Carla Boetes
Journal:  Insights Imaging       Date:  2013-01-16

6.  Characterization of a murine xenograft model for contrast agent development in breast lesion malignancy assessment.

Authors:  Tsung-Hsien Yen; Gi-Da Lee; Jyn-Wen Chai; Jiunn-Wang Liao; Jia-Yu Lau; Li-Che Hu; Kuo-Chih Liao
Journal:  J Biomed Sci       Date:  2016-05-17       Impact factor: 8.410

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.